Veeva Systems Inc
VEEV
$171.36 8.40% Quote
Exchange NYSE Sector Healthcare Industry Medical Healthcare Information Services
Q1 2026
Reported
Published: Jun 2, 2025

Data: Financial Modeling Prep

Company Status Snapshot

Fast view of the latest quarter outcome for VEEV

Report Date

Jun 2, 2025

Quarter Q1 2026

Revenue

759.04M

YoY: +16.7%

EPS

1.37

YoY: +40.0%

Market Move

+8.40%

Previous quarter: Q4 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Gross Margin

77.1%

Net Income

228.19M

YoY: +41.2%

It was a strong start to the year with results above our guidance. Calendar 2025 revenue run rate goal of $3 billion. Veeva AI is a major initiative and off to a good start.

— Peter Gassner
VEEV
Company VEEV

Swipe to view all report sections

Executive Summary

Veeva Systems reported a strong start to Q1 FY2026 (quarter ended April 30, 2025) with revenue of $759.0 million, delivering a YoY growth rate of 16.7% and QoQ growth of 5.3%. The quarter featured robust profitability, highlighted by a non-GAAP operating margin of approximately 32% and net income of $228.2 million, translating to EPS of $1.40 (GAAP) and $1.37 (diluted). Management underscored that the results exceeded guidance and cited a tangible path toward a calendar 2025 revenue run rate of $3.0 billion. A cornerstone of the upside is Crossix, which contributed meaningfully to revenue strength and is supported by a broader data-and-analytics ecosystem (Data Cloud, LINC Compass). Vault CRM adoption progressed, with roughly 80 customers live versus a 200-customer target for year-end, underscoring early momentum in horizontal growth alongside the core life sciences franchise. Veeva AI is advancing as a major strategic initiative embedded in core applications, with management signaling AI agents and deeper integration by year-end. The macro backdrop remains uncertain, but the company reported no material impact to results or pipeline to date, reinforcing the durability of its subscription-led model and large, multi-year deals. The company reaffirmed its growth runway into 2030, with a heavy emphasis on AI-enabled productivity, horizontal CRM expansion, and continued expansion of Crossix and data cloud capabilities. Overall, the combination of strong cash flow generation, a healthy balance sheet, and a clear AI-enabled product roadmap supports an constructive investor thesis, albeit with near-term macro-driven visibility risk.

Key Performance Indicators

Revenue
Increasing
759.04M
QoQ: 5.29% | YoY: 16.71%
Gross Profit
Increasing
585.22M
77.10% margin
QoQ: 8.39% | YoY: 22.83%
Operating Income
Increasing
233.73M
QoQ: 24.05% | YoY: 50.63%
Net Income
Increasing
228.19M
QoQ: 16.65% | YoY: 41.15%
EPS
Increasing
1.40
QoQ: 16.67% | YoY: 40.00%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2026 835.95 1.45 +16.0% View
Q3 2026 811.24 1.40 +16.0% View
Q2 2026 789.08 1.19 +16.7% View
Q1 2026 759.04 1.37 +16.7% View
Q4 2025 720.89 1.18 +14.3% View